OncoGenex Pharmaceuticals (OGXI)

Add to Watchlists
Create an Alert
2.11 +0.02  +0.96% NASDAQ Nov 26, 8:00PM BATS Real time Currency in USD
View Full Chart
OGXI Price Chart
View All Events

OGXI Events

Date Type Description
10/30/2014 16:30 EDT Misc Q3 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
10/30/2014 Earnings Q3 2014 OncoGenex Pharmaceuticals Inc Earnings Result
08/07/2014 16:30 EDT Misc Q2 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
08/07/2014 Earnings Q2 2014 OncoGenex Pharmaceuticals Inc Earnings Results
04/30/2014 16:30 EDT Misc Q1 2014 OncoGenex Pharmaceuticals Inc Earnings Conference Call
04/30/2014 Earnings Q1 2014 OncoGenex Pharmaceuticals Inc Earnings Results
03/11/2014 16:30 EDT Misc OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
03/11/2014 Earnings OncoGenex Pharmaceuticals, Inc. Q4 2013 Earning Result
View All Performance Charts

OGXI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OncoGenex Pharmaceuticals is down 74.14% over the last year vs S&P 500 Total Return up 17.38%, Isis Pharmaceuticals up 38.31%, and GlycoMimetics up N/A.

Get Quote for
Advertisement

Portfolio Strategies Featuring OGXI

Did OncoGenex Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OGXI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oncogenex.com
  • IR Website: http://ir.oncogenex.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: In-Vitro Diagnostic Substance Manufacturing
  • NAICS Code: 325413
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OncoGenex Pharmaceuticals Inc is a biopharmaceutical company engaged in the development & commercialization of therapies that address treatment resistance in cancer patients. It has three product candidates in pipeline: custirsen, apatorsen & OGX-225.

OGXI Excel Add-In Codes

  • Name: =YCI("OGXI","name")
  • Description: =YCI("OGXI","description")
  • Sector: =YCI("OGXI","sector")
  • Industry: =YCI("OGXI","industry")
  • Est. Current Fiscal Year End: =YCI("OGXI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.